We are live on ! Find out more
HSCSW icon

HeartSciences Inc Warrant
HSCSW

3 hedge funds and large institutions have $23.2K invested in HeartSciences Inc Warrant in 2026 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3 → 3 (0)

0.29% less ownership

Funds ownership: 26.54% → 26.25% (-0.29%)

57% less capital invested

Capital invested by funds: $53.8K → $23.2K (-$30.6K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$309

HSCSW Hedge Fund Activity: Q2 2026 in Review

3 of the 8,337 institutional investors tracked by Wall St. Rank reported a position in HeartSciences Inc Warrant (HSCSW) for Q2 2026, worth a combined $23.2K — down 57% from $53.8K a quarter earlier.

Fund positioning in HSCSW was balanced in Q2 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Citadel Advisors, cutting an estimated $309.

  • 3 institutional investors held HeartSciences Inc Warrant (HSCSW) as of Q2 2026, unchanged from Q1 2026.
  • Funds reported $23.2K of HeartSciences Inc Warrant stock for Q2 2026, down 57% quarter-over-quarter.
  • 0 funds opened new HeartSciences Inc Warrant positions in Q2 2026 and 0 closed out.
  • The largest HeartSciences Inc Warrant seller in Q2 2026 was Citadel Advisors, an estimated $309 sold.

Based on aggregated 13F filings for Q2 2026.